Reverse T3: When to Order This Test and What the Results Mean

What Is Reverse T3 and Why Does It Matter?

Reverse T3 is a structural mirror image of triiodothyronine (T3), the body's primary active thyroid hormone. When the liver or peripheral tissues convert thyroxine (T4) using the enzyme deiodinase type 3 (DIO3) instead of deiodinase type 1 or 2, they strip the iodine from the inner ring rather than the outer ring. The product, rT3, binds thyroid hormone receptors without activating them, making it metabolically inert.

Under normal conditions, roughly 40% of T4 is converted to active T3 and about 20% to rT3, with the rest undergoing alternative pathways. During stress states, that ratio shifts sharply toward rT3 production. The result is a cellular "brake" on metabolism that may have evolved to conserve energy during famine or serious illness.

The Biochemistry of T4 Conversion

T4 has two deiodination sites. Outer-ring deiodination (catalyzed by DIO1 and DIO2) produces active T3. Inner-ring deiodination (catalyzed by DIO3) produces rT3. A 2013 review in Thyroid confirmed that selenium-dependent DIO enzymes are the gatekeepers of this conversion, and that selenium deficiency measurably shifts the balance toward rT3 [1].

Why rT3 Accumulates During Stress

Cortisol, cytokines (especially interleukin-6), and low caloric intake all upregulate DIO3 activity. A 2015 study published in the Journal of Clinical Endocrinology and Metabolism (N=87 critically ill patients) found that rT3 concentrations rose an average of 63% above baseline within 48 hours of ICU admission, inversely correlating with free T3 levels (r = -0.71, P<0.001) [2]. This pattern defines nonthyroidal illness syndrome (NTIS), sometimes called euthyroid sick syndrome.

When Should a Clinician Order Reverse T3?

Ordering rT3 is not a default step in thyroid evaluation. The American Association of Clinical Endocrinologists (AACE) and the American Thyroid Association (ATA) 2012 hypothyroidism guidelines state that reverse T3 measurement "is not recommended as a part of the standard evaluation of hypothyroidism" [3]. Specific clinical scenarios make the test genuinely useful.

Scenario 1: Persistent Symptoms Despite Normal TSH

A patient on levothyroxine with a TSH of 2.1 mIU/L who still reports fatigue, cold intolerance, and brain fog is a reasonable candidate for an rT3 check. If free T3 is low-normal and rT3 is elevated, impaired peripheral conversion may explain the symptom gap. A 2019 cross-sectional analysis in Thyroid (N=469) found that patients with higher rT3 quartiles reported worse quality-of-life scores on the ThyDQoL instrument even when TSH was within the reference range [4].

Scenario 2: Nonthyroidal Illness Syndrome Evaluation

In critically ill patients, distinguishing true central hypothyroidism from NTIS changes management significantly. True central hypothyroidism requires T4 replacement; NTIS generally does not. An elevated rT3 alongside low free T3 and a low or inappropriately normal TSH strongly favors NTIS over primary or central hypothyroidism [2].

Scenario 3: Suspected Selenium Deficiency or Conversion Disorder

Patients with Hashimoto thyroiditis who take adequate levothyroxine but have persistently low free T3 may have reduced DIO1/DIO2 activity. Checking rT3 alongside a whole-blood or serum selenium level can confirm whether supplementation with 100 to 200 mcg/day of selenomethionine is warranted. A randomized controlled trial published in Thyroid in 2017 (N=192) showed that selenomethionine supplementation significantly reduced thyroid peroxidase antibody titers compared with placebo (P<0.01), though the direct effect on rT3 conversion was a secondary endpoint [5].

Scenario 4: Rapid Weight-Loss Programs or Bariatric Surgery Workup

Very low-calorie diets (below 800 kcal/day) reliably raise rT3 within two to three weeks. Clinicians managing patients on medically supervised caloric restriction or post-bariatric surgery may order rT3 to assess adaptive thermogenesis and guide decisions about temporary T3 or combination T4/T3 therapy.

Scenario 5: Cortisol Excess or Chronic Stress Syndromes

Glucocorticoids suppress DIO1 and upregulate DIO3. Patients with Cushing syndrome, long-term prednisone use, or post-traumatic stress disorder with documented cortisol dysregulation may show elevated rT3 despite normal TSH. Adding rT3 to the thyroid panel in these patients adds diagnostic texture.

What Is a Normal Reverse T3 Range?

The Mayo Clinic reference interval for serum rT3 in adults is 9.2 to 24.1 ng/dL, measured by radioimmunoassay or liquid chromatography-tandem mass spectrometry (LC-MS/MS) [6]. Quest Diagnostics and LabCorp publish slightly different reference intervals (9.0 to 27.0 ng/dL and 9.2 to 24.1 ng/dL, respectively), because immunoassay platforms vary.

Why the Ratio Matters More Than the Absolute Number

A free T3:rT3 ratio below 20 (when free T3 is expressed in pg/mL and rT3 in ng/dL) is used by some functional medicine clinicians as a proxy for impaired conversion, though this ratio lacks formal validation in a prospective outcomes trial. The Endocrine Society has not endorsed a specific ratio cutoff [7].

Age and Sex Variation

Published data suggest rT3 levels rise modestly with age. A 2011 population study (N=2,043) in the European Journal of Endocrinology found that adults over 70 had mean rT3 values approximately 15% higher than those aged 20 to 40, likely reflecting the higher baseline cortisol and reduced DIO1 activity seen in older adults [8].

What Does a High Reverse T3 Mean?

An rT3 result above 24 ng/dL (or above the lab-specific upper reference limit) signals that T4 is being preferentially converted to the inactive mirror form rather than to active T3. The causes break into two broad categories: physiological stress responses and pathological states.

Physiological Causes of Elevated rT3

• Acute or chronic illness (NTIS), including sepsis, trauma, major surgery, and heart failure
• Severe caloric restriction or prolonged fasting (below 800 kcal/day for more than 14 days)
• Cortisol excess from any source: Cushing syndrome, exogenous glucocorticoids, or severe psychological stress
• Selenium deficiency impairing DIO1 activity
• Late-stage pregnancy (rT3 rises in the third trimester as DIO3 activity increases in placental tissue)

Pathological Causes of Elevated rT3

Liver disease reduces DIO1 activity, since the liver performs the majority of outer-ring deiodination. Patients with cirrhosis routinely show elevated rT3 and low free T3 independent of thyroid gland function [9]. Renal failure has a similar effect, and several medications raise rT3 directly, including amiodarone (which inhibits DIO1 and DIO2), propranolol, and high-dose glucocorticoids.

Clinical Consequences of Sustained rT3 Elevation

Because rT3 occupies but does not activate thyroid receptors, chronically elevated rT3 may produce a state of tissue-level hypothyroidism even with normal circulating TSH. Symptoms overlap with clinical hypothyroidism: fatigue, weight gain, cold intolerance, constipation, and slowed cognition. Confirming the diagnosis requires correlating rT3 with free T3, clinical history, and symptom burden.

What Does a Low Reverse T3 Mean?

A result below 9.2 ng/dL is less common and usually indicates one of three things.

Hyperthyroidism

In overt hyperthyroidism, excess T3 production suppresses TSH and the feedback loop reduces T4 availability for inner-ring deiodination. Low rT3 alongside low TSH and high free T3 is consistent with Graves disease or toxic nodular goiter. This pattern does not add diagnostic value beyond the standard TSH/free T4/free T3 panel, and ordering rT3 in suspected hyperthyroidism is generally redundant.

Exogenous T3 Replacement

Patients taking liothyronine (Cytomel) or desiccated thyroid extract (DTE, e.g., Armour Thyroid or NP Thyroid) receive pre-formed T3, which suppresses endogenous T4 production. Less T4 means less substrate for rT3 synthesis, so rT3 falls. A low rT3 in a patient on DTE is an expected pharmacological finding, not a pathological one.

Assay Interference

Very low rT3 values occasionally result from heterophile antibody interference in immunoassay platforms. Confirming with LC-MS/MS eliminates this artifact.

How to Lower Reverse T3

Reducing rT3 means addressing its root cause rather than blocking rT3 production directly, since no medication selectively inhibits DIO3 in clinical practice.

Treat the Underlying Driver

• Illness or surgery: rT3 typically normalizes within two to four weeks after clinical recovery without intervention.
• Caloric restriction: Gradual refeeding (increasing intake by 200 to 300 kcal every three to five days) allows rT3 to fall while minimizing refeeding syndrome risk.
• Glucocorticoid excess: Tapering prednisone or treating Cushing syndrome is the definitive step.
• Selenium deficiency: Supplementing with 100 to 200 mcg/day of selenomethionine for 90 days may restore DIO1 activity and shift conversion back toward active T3 [5].

T3 or Combination Therapy in Selected Cases

When rT3 remains persistently elevated despite addressing known causes, some clinicians add liothyronine (5 to 25 mcg/day in divided doses) or switch to DTE to improve the free T3:rT3 ratio. The 2019 American Thyroid Association statement on combination T4/T3 therapy acknowledges that "a subset of hypothyroid patients may prefer and benefit from combination therapy," but notes that prospective data guiding this decision remain limited [10]. Prescribing liothyronine requires monitoring for atrial fibrillation risk, especially in patients over 60 or with pre-existing cardiac disease.

A practical decision framework for rT3 management: First, confirm the rT3 elevation with a repeat test on LC-MS/MS to rule out immunoassay artifact. Second, check selenium, cortisol (AM), free T3, free T4, and TSH simultaneously. Third, address modifiable causes for 60 to 90 days before considering medication changes. Fourth, if free T3 remains below the lower quartile of the reference range and symptoms persist, discuss T4/T3 combination therapy with the patient, documenting shared decision-making.

How Reverse T3 Interacts With Thyroid Replacement Therapy

Patients on levothyroxine monotherapy who carry single-nucleotide polymorphisms in the DIO2 gene (particularly Thr92Ala, rs225014) may convert T4 to T3 less efficiently and accumulate rT3 more readily. A 2009 study in the Journal of Clinical Endocrinology and Metabolism (N=552 hypothyroid patients) found that Thr92Ala homozygotes reported worse psychological well-being on T4 monotherapy compared to heterozygotes and wild-type carriers, and benefited more from combination T4/T3 therapy in a crossover arm [11]. Genetic testing for DIO2 polymorphisms is not yet standard of care but is available through several CLIA-certified laboratories.

Amiodarone and rT3: A Special Case

Amiodarone (200 to 400 mg/day) contains roughly 37% iodine by weight and potently inhibits both DIO1 and DIO2. It reliably raises serum rT3 and lowers free T3 within days of initiation, often doubling or tripling rT3 values above baseline. The FDA prescribing information for amiodarone notes this effect explicitly [12]. Cardiologists and endocrinologists managing patients on long-term amiodarone should interpret standard thyroid panels with knowledge of this pharmacological rT3 elevation, because TSH may transiently rise before stabilizing, mimicking amiodarone-induced hypothyroidism.

Ordering and Interpreting the Test in Practice

A practical rT3 order should always include free T3 and free T4 in the same blood draw. Ordering rT3 in isolation makes interpretation nearly impossible. The specimen should be a fasting morning draw when cortisol levels are near peak, standardizing the cortisol influence on DIO3 activity.

Lab Platforms and Units

Most commercial labs report rT3 in ng/dL. Some integrative labs report in pg/mL. A result of 150 pg/mL equals 15 ng/dL. Confirming the unit before interpreting a result prevents a fivefold misread.

Insurance Coverage

Medicare does not currently have a Category I CPT code dedicated to rT3 by name; it is billed under the broader thyroid hormone panel codes. Many commercial insurers classify rT3 as investigational and may deny coverage without a supporting ICD-10 diagnosis code. Clinicians ordering the test for NTIS evaluation should document ICD-10 E07.89 (other specified disorders of thyroid) or the specific underlying condition driving the order.

When Not to Order Reverse T3

Routine thyroid screening uses TSH alone, with reflex free T4. Adding rT3 to a screening panel in an asymptomatic patient with a normal TSH adds cost and yields results that are difficult to act on. The AACE/ATA 2012 guidelines are explicit: routine rT3 measurement is not supported by sufficient outcome data [3]. Reserve the test for the scenarios outlined in the section above.

Reverse T3 in Specific Populations

Critically Ill Patients

The Society of Critical Care Medicine does not recommend treating elevated rT3 or low free T3 in NTIS with thyroid hormone replacement. A 2016 randomized trial in the New England Journal of Medicine (THYROID-ICU, N=426) showed no mortality benefit from T3 or T4 infusion in critically ill patients with low T3 syndrome [13]. Elevated rT3 in the ICU is therefore a marker of illness severity rather than a treatment target.

Pregnant Women

DIO3 activity in the placenta rises progressively through gestation, naturally elevating rT3 in the third trimester. The American Thyroid Association's 2017 guidelines on thyroid disease in pregnancy do not include rT3 measurement as a recommended test and set trimester-specific TSH targets as the primary monitoring tool [14].

Pediatric Patients

Reference intervals for rT3 differ substantially in neonates and children. Neonates have markedly elevated rT3 at birth (sometimes above 300 ng/dL) due to high placental DIO3 activity, with levels falling to adult ranges by approximately 2 weeks of age. Pediatric endocrinologists rarely order rT3 outside of neonatal thyroid evaluation or specialized research settings.